The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
PARP-1 Inhibition Prevents Oxidative and Nitrosative Stress–Induced Endothelial Cell Death via Transactivation of the VEGF Receptor 2
Abstract
Objective— PARP-1, a DNA base repair enzyme, is activated by DNA breaks induced by oxidative (ROS) and nitrosative (RNS) stress. By consuming NAD + , PARP-1 activation can lead to ATP depletion and cell death. Studies suggest that inhibiting PARP-1 activity can attenuate pathologies associated with vascular smooth muscle and endothelial dysfunction. PARP-1 inhibition can also activate the prosurvival serine/threonine kinase, Akt. Vascular endothelial growth factor (VEGF) regulates endothelial cell survival via Akt activation downstream of VEGF receptor 2 (VEGFR2) activation. Here we investigated the hypothesis that PARP-1 inhibition protects human umbilical vein endothelial cells (HUVECs) from ROS- and RNS-induced cell death by limiting NAD + depletion and by activating a prosurvival signaling pathway via VEGFR2 phosphorylation. Methods and Results— We activated PARP-1 in HUVECs by treatment with hydrogen peroxide (H 2 O 2 ) and peroxynitrite (ONOO − ). Both depleted HUVECs of NAD + and ATP, processes that were limited by the PARP-1 inhibitor, PJ34. ONOO − and H 2 O 2 -induced cell death and apoptosis were attenuated in cells treated with PJ34 or PARP-1 siRNA. PARP-1 inhibition increased Akt, BAD, and VEGFR2 phosphorylation in HUVECs and in PJ34-treated rabbit aortas. The VEGFR2-specific tyrosine kinase inhibitor SU1498 decreased PARP-1 inhibition-mediated phosphorylation of VEGFR2 and Akt, and also reversed survival effects of PJ34. Finally, PARP-1 inhibition protected cells from death induced by serum starvation, evidence for a role in cell survival independent of energy protection. Conclusions— PARP-1 inhibition prevents ROS- and RNS-induced HUVEC death by maintaining cellular energy in the form of NAD + and ATP, and also by activating a survival pathway via VEGFR2, Akt, and BAD phosphorylation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“They sensitize tumours to DNA damage, but they have limited use due to toxicity223–225.”
From NAD+ metabolism and its roles in cellular processes during ageing (2021) · cites this paper as [225]
Citations
Cites
Biochemistry and molecular cell biology of diabetic complications
Brownlee, M. (2001) · Nature · doi:10.1038/414813a · Cited by 9,107
Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery
Datta, S. R., Dudek, H., Tao, X., Masters, S., Fu, H., Gotoh, Y., & Greenberg, M. E. (1997) · Cell · doi:10.1016/s0092-8674(00)80405-5 · Cited by 5,689
Role of Oxidative Modifications in Atherosclerosis
Stocker, R., & Keaney, J. F. (2004) · Physiological Reviews · doi:10.1152/physrev.00047.2003 · Cited by 2,651
Asahara, T., Takahashi, T., Masuda, H., Kalka, C., Chen, D., Iwaguro, H., Inai, Y., Silver, M., & Isner, J. M. (1999) · The EMBO Journal · doi:10.1093/emboj/18.14.3964 · Cited by 1,851
14-3-3 Proteins and Survival Kinases Cooperate to Inactivate BAD by BH3 Domain Phosphorylation
Datta, S. R., Katsov, A., Hu, L. S., Petros, A. M., Fesik, S. W., Yaffe, M. B., & Greenberg, M. E. (2000) · Molecular Cell · doi:10.1016/s1097-2765(05)00012-2 · Cited by 663
Nor, J. E., Christensen, J. B., Mooney, D. J., & Polverini, P. J. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65284-4 · Cited by 645
Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation
Soriano, F. G., Virág, L., Jagtap, P. G., Szabó, É., Mabley, J. G., Liaudet, L., Marton, A., Hoyt, D. G., Murthy, K. G. K., Salzman, A. L., et al. (2001) · Nature Medicine · doi:10.1038/83241 · Cited by 602
Poly(ADP-ribose) polymerase-1: what have we learned from the deficient mouse model?
Shall, S., & de MURCIA, G. (2000) · Mutation Research/DNA Repair · doi:10.1016/s0921-8777(00)00016-1 · Cited by 534
Jin, Z., Ueba, H., Tanimoto, T., Lungu, A. O., Frame, M. D. S., & Berk, B. C. (2003) · Circulation Research · doi:10.1161/01.res.0000089257.94002.96 · Cited by 380
Self-citationThe Enzymatic and DNA Binding Activity of PARP-1 Are Not Required for NF-κB Coactivator Function
Hassa, P. O., Covic, M., Hasan, S., Imhof, R., & Hottiger, M. O. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106528200 · Cited by 309
Cited by
Sorted by citations
NAD+ metabolism and its roles in cellular processes during ageing
Covarrubias, A. J., Perrone, R., Grozio, A., & Verdin, E. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-00313-x · Cited by 1,617
Incalza, M. A., D’Oria, R., Natalicchio, A., Perrini, S., Laviola, L., & Giorgino, F. (2017) · Vascular Pharmacology · doi:10.1016/j.vph.2017.05.005 · Cited by 1,419
Therapeutic Potential of NAD-Boosting Molecules: The In Vivo Evidence
Rajman, L., Chwalek, K., & Sinclair, D. A. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.02.011 · Cited by 865
Parthanatos: mitochondrial‐linked mechanisms and therapeutic opportunities
Fatokun, A. A., Dawson, V. L., & Dawson, T. M. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12416 · Cited by 594
ROS-triggered endothelial cell death mechanisms: Focus on pyroptosis, parthanatos, and ferroptosis
Zheng, D., Liu, J., Piao, H., Zhu, Z., Wei, R., & Liu, K. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1039241 · Cited by 592
The inflammatory response in sepsis
Bosmann, M., & Ward, P. A. (2012) · Trends in Immunology · doi:10.1016/j.it.2012.09.004 · Cited by 559
Molecular Biology of Atherosclerosis
Hopkins, P. N. (2013) · Physiological Reviews · doi:10.1152/physrev.00004.2012 · Cited by 469
Thomas, S. R., Witting, P. K., & Drummond, G. R. (2008) · Antioxidants & Redox Signaling · doi:10.1089/ars.2008.2027 · Cited by 383
Banerjee, S. N., & Kaye, S. B. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-2243 · Cited by 368
Nakamura, Y., Kawazoe, A., Lordick, F., Janjigian, Y. Y., & Shitara, K. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-021-00492-2 · Cited by 307
Targeting protein modifications in metabolic diseases: molecular mechanisms and targeted therapies
Wu, X., Xu, M., Geng, M., Chen, S., Little, P. J., Xu, S., & Weng, J. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01439-y · Cited by 295
Qiao, X., Yin, J., Zheng, Z., Li, L., & Feng, X. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01620-y · Cited by 219
Lu, M., Hu, L., Hu, G., & Bian, J. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.09.014 · Cited by 187
Nicotinamide Phosphoribosyltransferase in Malignancy: A Review
Shackelford, R. E., Mayhall, K., Maxwell, N. M., Kandil, E. H., & Coppola, D. (2013) · Genes & Cancer · doi:10.1177/1947601913507576 · Cited by 127
Nitrosative Stress and Its Association with Cardiometabolic Disorders
Pérez-Torres, I., Manzano-Pech, L., Rubio-Ruiz, M. E., Soto, M. E., & Guarner‐Lans, V. (2020) · Molecules · doi:10.3390/molecules25112555 · Cited by 129
Wang, T., Wang, L., Moreno‐Vinasco, L., Lang, G. D., Siegler, J. H., Mathew, B., Usatyuk, P. V., Samet, J. M., Geyh, A. S., Breysse, P. N., et al. (2012) · Particle and Fibre Toxicology · doi:10.1186/1743-8977-9-35 · Cited by 117
Making the best of PARP inhibitors in ovarian cancer
Banerjee, S. N., Kaye, S. B., & Ashworth, A. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.116 · Cited by 107
Byun, J., Kim, M., Eum, D., Yoon, C., Seo, W. D., Park, K. H., Hyun, J. W., Lee, Y., Lee, J., Yoon, M., et al. (2009) · Molecular Pharmacology · doi:10.1124/mol.109.056259 · Cited by 86
Roy, B. (2025) · Medical Sciences · doi:10.3390/medsci13030087 · Cited by 103
The Role of Oxidative Stress in Acute Ischemic Stroke‐Related Thrombosis
Li, Z., Bi, R., Sun, S., Chen, S., Chen, J., Hu, B., & Jin, H. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/8418820 · Cited by 76
Subcellular Localization of Oxidants and Redox Modulation of Endothelial Nitric Oxide Synthase
Maron, B. A., & Michel, T. M. (2012) · Circulation Journal · doi:10.1253/circj.cj-12-1207 · Cited by 78
Kwok, H., Ng, W. Y., Yang, M. S. M., Mak, N. K., Wong, R. N., & Yue, P. Y. K. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.11.013 · Cited by 74
Naked mole rat cells display more efficient excision repair than mouse cells
Evdokimov, A. N., Kutuzov, M. M., Petruseva, I. O., Lukjanchikova, N., Kashina, E. V., Kolova, E., Zemerova, T., Romanenko, S. A., Perelman, P. L., Prokopov, D., et al. (2018) · Aging · doi:10.18632/aging.101482 · Cited by 73
AMPKα2 exerts its anti-inflammatory effects through PARP-1 and Bcl-6
Gongol, B., Marin, T., Peng, I.-C., Woo, B., Martin, M., King, S., Sun, W., Johnson, D. A., Chien, S., & Shyy, J. Y.-J. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1222051110 · Cited by 61
Saad, M. I., Abdelkhalek, T. M., Saleh, M. M., Kamel, M. A. E.-N., Youssef, M., Tawfik, S. H., & Domínguez, H. (2015) · Endocrine · doi:10.1007/s12020-015-0709-4 · Cited by 61
Alonso, V., Gortázar, A. R., Ardura, J. A., Andrade‐Zapata, I., Alvarez-Arroyo, M. V., & Esbrit, P. (2008) · Journal of Cellular Physiology · doi:10.1002/jcp.21547 · Cited by 59
Li, F., Abuarab, N., & Sivaprasadarao, A. (2016) · Journal of Cell Science · doi:10.1242/jcs.179796 · Cited by 60
Effect of Diabetes Mellitus on the Pharmacokinetics and Pharmacodynamics of Tuberculosis Treatment
Alfarisi, O., Mave, V., Gaikwad, S., Sahasrabudhe, T. R., Ramachandran, G., Kumar, H., Gupte, N., Kulkarni, V., Deshmukh, S., Atre, S. R., et al. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01383-18 · Cited by 60
Signaling pathways in brain ischemia: Mechanisms and therapeutic implications
Lin, W., Zhao, X., Cheng, J., Li, L., Jiang, Q., Zhang, Y., & Han, F. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108541 · Cited by 61
Hemorrhagic Transformation After Tissue Plasminogen Activator Treatment in Acute Ischemic Stroke
Liu, C., Xie, J., Sun, S., Li, H., Li, T., Jiang, C. Q., Chen, X., Wang, J., Le, A., Wang, J., et al. (2020) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-020-00985-1 · Cited by 61
The role of Cediranib in ovarian cancer
Orbegoso, C., Marquina, G., George, A. J., & Banerjee, S. N. (2017) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2017.1383384 · Cited by 52
Peroxynitrite Induces Gene Expression in Intervertebral Disc Cells
Poveda, L., Hottiger, M. O., Boos, N., & Wuertz‐Kozak, K. (2009) · Spine · doi:10.1097/brs.0b013e31819f2330 · Cited by 47
Rom, S., Zuluaga‐Ramirez, V., Reichenbach, N. L., Dykstra, H., Gajghate, S., Pacher, P., & Persidsky, Y. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0729-x · Cited by 52
Targeted Therapy in Ovarian Cancer
Lim, H. J., & Ledger, W. J. (2016) · Women s Health · doi:10.2217/whe.16.4 · Cited by 46
PARP and PARG Inhibitors—New Therapeutic Targets in Cancer Treatment
Fauzee, N. J. S., Pan, J., & Wang, Y. (2010) · Pathology & Oncology Research · doi:10.1007/s12253-010-9266-6 · Cited by 46
The Cardiovascular Therapeutic Potential of Propolis—A Comprehensive Review
Silva, H., Francisco, R. C., Saraiva, A., Francisco, S., Carrascosa, C., & Raposo, A. (2021) · Biology · doi:10.3390/biology10010027 · Cited by 71
Shang, F., Zhang, J., Li, Z., Zhang, J., Yin, Y., Wang, Y., Marin, T., Gongol, B., Xiao, H., Zhang, Y., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0151845 · Cited by 44
Role of Sirtuins in Tumor Angiogenesis
Edatt, L., Poyyakkara, A., Raji, G. R., Ramachandran, V., Shankar, S. S., & Kumar, V. B. S. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2019.01516 · Cited by 43
MicroRNAs Modulate Oxidative Stress in Hypertension through PARP‐1 Regulation
Dluzen, D. F., Kim, Y., Bastian, P., Zhang, Y., Lehrmann, E., Becker, K. G., Hooten, N. N., & Evans, M. K. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/3984280 · Cited by 41
Zarkasi, K. A., Murad, N. A. A., Ahmad, N., Jamal, R., & Abdullah, N. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19020647 · Cited by 39
TDP1 and PARP1 Deficiency Are Cytotoxic to Rhabdomyosarcoma Cells
Fam, H. K., Walton, C., Mitra, S. A., Chowdhury, M. K., Osborne, N., Choi, K., Sun, G., Wong, P. C. W., O’Sullivan, M. J., Turashvili, G., et al. (2013) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-12-0575 · Cited by 39
Bosseboeuf, E., & Raimondi, C. (2020) · Cells · doi:10.3390/cells9092055 · Cited by 38
Exploring the role of parthanatos in CNS injury: Molecular insights and therapeutic approaches
Zhang, J., Hu, X., Geng, Y., Xiang, L., Wu, Y., Li, Y., Yang, L., & Zhou, K. (2024) · Journal of Advanced Research · doi:10.1016/j.jare.2024.04.031 · Cited by 40
Wu, X., Deng, G., Li, M., Li, Y., Ma, C., Wang, Y., & Liu, X. (2015) · BMC Immunology · doi:10.1186/s12865-015-0080-5 · Cited by 37
Hao, T., & Rockwell, P. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.05.036 · Cited by 37
Wang, C., Zhang, F., Wang, L., Zhang, Y., Li, X., Huang, K., Du, M., Liu, F., Huang, S., Guan, Y., et al. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.00160-13 · Cited by 37
The Molecular Basis of COVID-19 Pathogenesis, Conventional and Nanomedicine Therapy
Kouhpayeh, S., Shariati, L., Boshtam, M., Rahimmanesh, I., Mirian, M., Esmaeili, Y., Najaflu, M., Khanahmad, N., Zeinalian, M., Trovato, M., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115438 · Cited by 35
Thioredoxin-Interacting Protein Mediates Nuclear–to–Plasma Membrane Communication
Spindel, O. N., Chen, Y., & Berk, B. C. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.244681 · Cited by 34
Self-citationMitochondrial mechanisms in amyloid beta peptide-induced cerebrovascular degeneration
Hsu, M., Sheu, J., Lin, C., Shen, M., & Hsu, C. Y. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2009.08.003 · Cited by 34
Shin, S.-J., Moon, K. C., Park, K. U., & Ha, E. (2012) · Biochimie · doi:10.1016/j.biochi.2012.03.023 · Cited by 34
Vaschetto, R., Kuiper, J. W., Musters, R. J. P., Eringa, E. C., Corte, F. D., Murthy, K. G. K., Groeneveld, A. B. J., & Plötz, F. B. (2010) · Critical Care · doi:10.1186/cc8932 · Cited by 33
Oxidative Stress Genes, Antioxidants and Coronary Artery Disease in Type 2 Diabetes Mellitus
Tibaut, M., & Petrovi, D. (2016) · Cardiovascular & Hematological Agents in Medicinal Chemistry · doi:10.2174/1871525714666160407143416 · Cited by 34
NAMPT and NAMPT-controlled NAD Metabolism in Vascular Repair
Wang, P., Li, W., Liu, J., & Miao, C. (2015) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000332 · Cited by 33
Critical role of bad phosphorylation by Akt in cytostatic resistance of human bladder cancer cells.
Szántó, Á., Bognár, Z., Szigeti, A., Szabó, A., Farkas, L., & Gallyas, F. (2009) · PubMed · Cited by 35
Oxidative stress: An essential factor in the process of arteriovenous fistula failure
Hu, K., Guo, Y., Li, Y., Lu, C., Cai, C., Zhou, S., Ke, Z., Li, Y., & Wang, W. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.984472 · Cited by 33
Li, W. J., Zhou, J., Li, B., Wang, H., Peng, Y. B., & Wang, Z. (2011) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2010.02176.x · Cited by 30
Lee, J., Trepel, J. B., Choyke, P. L., Cao, L., Sissung, T. M., Houston, N. D., Yu, M., Figg, W. D., Turkbey, I. B., Steinberg, S. M., et al. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00123 · Cited by 26
Protein kinase C: A potential therapeutic target for endothelial dysfunction in diabetes
Xiao, Q., Wang, D., Li, D., Huang, J. H., Ma, F., Zhang, H., Sheng, Y., Zhang, C., & Ha, X. (2023) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2023.108565 · Cited by 25
Methyltransferase Set7/9 as a Multifaceted Regulator of ROS Response
Daks, A. A., Shuvalov, O. Y., Fedorova, O., Parfenyev, S. E., Simon, H., & Barlev, N. A. (2023) · International Journal of Biological Sciences · doi:10.7150/ijbs.83158 · Cited by 25
Broniowska, K. A., Diers, A. R., Corbett, J. A., & Hogg, N. (2013) · Biochemistry · doi:10.1021/bi400342t · Cited by 24
Cseh, A. M., Fábián, Z., Sümegi, B., & Scorrano, L. (2017) · Oncotarget · doi:10.18632/oncotarget.16859 · Cited by 26
PARP1 inhibition protects mice against Japanese encephalitis virus infection
Desingu, P. A., Mishra, S., Dindi, L., Srinivasan, S., Rajmani, R. S., Ravi, V., Tamta, A. K., Raghu, S., Murugasamy, K., Pandit, A. S., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.113103 · Cited by 23
Monte, M. D., Martini, D., Ristori, C., Azara, D., Armani, C., Balbarini, A., & Bagnoli, P. (2011) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-011-0625-y · Cited by 23
Gallorini, M., Maccallini, C., Ammazzalorso, A., Amoia, P., Filippis, B. D., Fantacuzzi, M., Giampietro, L., Cataldi, A., & Amoroso, R. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20030495 · Cited by 22
Shiravi, A., Saadatkish, M., Abdollahi, Z., Miar, P., Khanahmad, H., & Zeinalian, M. (2020) · International Journal for Vitamin and Nutrition Research · doi:10.1024/0300-9831/a000676 · Cited by 22
Huang, R., Gao, Y., Duan, Q., Zhang, Q., He, P., Chen, J., Ma, G., Wang, L., Zhang, Y., Nie, K., et al. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-03119-4 · Cited by 20
Hatachi, G., Tsuchiya, T., Miyazaki, T., Matsumoto, K., Yamasaki, N., Okita, N., Nanashima, A., Higami, Y., & Nagayasu, T. (2014) · Transplantation · doi:10.1097/tp.0000000000000305 · Cited by 20
Obesity drives depot-specific vascular remodeling in male white adipose tissue
Hasan, S. S., John, D., Rudnicki, M., AlZaim, I., Eberhard, D., Moll, I., Taylor, J., Klein, C., von Heesen, M., Conradi, L., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-60910-2 · Cited by 20
Role of PARP and TRPM2 in VEGF Inhibitor‐Induced Vascular Dysfunction
Neves, K. B., Alves-Lopes, R., Montezano, A. C. I., & Touyz, R. M. (2023) · Journal of the American Heart Association · doi:10.1161/jaha.122.027769 · Cited by 20
Involvement of poly(ADP-ribose) polymerase in paraptotic cell death of D. discoideum
Rajawat, J., Mir, H., Alex, T., Bakshi, S. R., & Begum, R. (2013) · APOPTOSIS · doi:10.1007/s10495-013-0920-9 · Cited by 18
Xanthine Oxidoreductase in the Pathogenesis of Endothelial Dysfunction: An Update
Mudgal, R. K., & Singh, S. (2024) · Current Hypertension Reviews · doi:10.2174/0115734021277772240124075120 · Cited by 14
Li, W. J., Peng, Y., Zhou, J., Li, B., Wang, H., Zhang, J., & Wang, Z. (2012) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2012.02666.x · Cited by 13
Son, J. N., Lho, Y., Shin, S., Kwon, S., Moon, K. C., & Ha, E. (2010) · International Journal of Cardiology · doi:10.1016/j.ijcard.2010.10.098 · Cited by 14
Qin, X., Wang, Y., Li, J., Xiao, Y., & Liu, Z. (2017) · Neoplasma · doi:10.4149/neo_2017_403 · Cited by 14
Sinha, A., Katyal, S., & Kauppinen, T. M. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108502 · Cited by 16
Chen, X., Mu, P., Zhu, L., Mao, X., Chen, S., Zhong, H., & Deng, Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22157936 · Cited by 15
Kim, G., Kim, H., Lim, H., & Park, H. (2015) · Cellular Signalling · doi:10.1016/j.cellsig.2015.04.012 · Cited by 14
Chamgordani, M. K., Bardestani, A., Ebrahimpour, S., & Esmaeili, A. (2023) · BMC Pharmacology and Toxicology · doi:10.1186/s40360-023-00725-3 · Cited by 12
Butcko, A. J., Putman, A. K., & Mottillo, E. P. (2024) · Antioxidants · doi:10.3390/antiox13010087 · Cited by 12
Deng, Y., Cai, Y., Liu, L., Lin, X., Pingfan, L., Guo, Y., Han, M. H., & Xu, G. (2018) · The FASEB Journal · doi:10.1096/fj.201800885rr · Cited by 12
Poly (ADP-ribose) Polymerase-1 modulations in the genesis of thrombosis
Safdar, R., Mishra, A., Shah, G. M., & Ashraf, M. Z. (2024) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-024-02974-3 · Cited by 9
The Role of Poly(ADP-Ribose) Polymerase-1 in Cutaneous Wound Healing
Banerjee, J., Lodhi, N., & Nguyen, B.-N. H. (2019) · Advances in Wound Care · doi:10.1089/wound.2018.0821 · Cited by 9
AlAhmad, M., Shitaw, E., & Sivaprasadarao, A. (2025) · Biomolecules · doi:10.3390/biom15081193 · Cited by 8
Castellano, G., Corti, C., Boldrini, L., Gervaso, L., Criscitiello, C., & Curigliano, G. (2023) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2023.102601 · Cited by 8
Xu, W., Wu, Y., Mao, R., Jia, Y., Jiang, H., Zhang, F., Huang, D. Y., He, X., Wang, C., & Huang, K. (2025) · Experimental & Molecular Medicine · doi:10.1038/s12276-025-01501-5 · Cited by 7
Lechaftois, M., Dréano, E., Palmier, B., Margaill, I., Marchand‐Leroux, C., Bachelot‐Loza, C., & Lerouet, D. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110776 · Cited by 7
Trafalis, D. T., Polonifi, A., Dalezis, P., Nikoleousakos, N., Katsamakas, S., & Sarli, V. (2017) · Chemical Biology & Drug Design · doi:10.1111/cbdd.13006 · Cited by 7
Can crosstalk between DOR and PARP reduce oxidative stress mediated neurodegeneration?
Raina, R., & Sen, D. (2017) · Neurochemistry International · doi:10.1016/j.neuint.2017.07.011 · Cited by 7
Capoluongo, E. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110536 · Cited by 7
Shafiq, M., Lone, Z. R., Abdulkareem, A. O., Kaur, G., Navya, S., Singh, H., Jagavelu, K., & Hanif, K. (2023) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2023.102200 · Cited by 6
Nikoleousakos, N., Dalezis, P., Polonifi, A., Geromichalou, E. G., Sagredou, S., Alifieris, C. E., Deligiorgi, M. V., Sarli, V., & Trafalis, D. T. (2021) · Biomedicines · doi:10.3390/biomedicines9081028 · Cited by 5
Molecular Mechanisms of Plant Extracts in Protecting Aging Blood Vessels
Luo, Y., Zhang, Z., Zheng, W., Zeng, Z., Fan, L., Zhao, Y., Huang, Y., Cao, S., Yu, S., & Shen, L. (2024) · Nutrients · doi:10.3390/nu16142357 · Cited by 4
Current Knowledge of Obesity‐Related Vascular Injury
Liu, J., & Yang, D. (2025) · Obesity Reviews · doi:10.1111/obr.70080 · Cited by 3
Inferring Molecular Processes Heterogeneity from Transcriptional Data
Gogolewski, K., Wronowska, W., Lech, A., Lesyng, B., & Gambin, A. (2017) · BioMed Research International · doi:10.1155/2017/6961786 · Cited by 3
Combining targeted therapies in ovarian cancer
Scambia, G., Salutari, V., & Ferrandina, G. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70421-8 · Cited by 3
Halldórsson, H., Thors, B., & Þorgeirsson, G. (2015) · Nucleosides Nucleotides & Nucleic Acids · doi:10.1080/15257770.2014.984072 · Cited by 3
The Sound of Silence: RNAi in Poly (ADP-Ribose) Research
Blenn, C., Wyrsch, P., & Althaus, F. (2012) · Genes · doi:10.3390/genes3040779 · Cited by 5
Behjati, M., Hashemi, M. M., Kazemi, M., Salehi, M., & Javanmard, S. H. (2017) · Advanced Biomedical Research · doi:10.4103/2277-9175.204591 · Cited by 3
Chen, X., Mu, P., Zhu, L., Mao, X., Chen, S., Zhong, H., & Deng, Y. (2021) · Research Square · doi:10.21203/rs.3.rs-506960/v1 · Cited by 3
Kuang, L., Chen, Q., Liu, Z., Wu, L., & Wu, S.-G. (2025) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000001728 · Cited by 2
Metadata
- Authors
- Mathews, M. T., & Berk, B. C.
- Affiliations
- University of Rochester Medicine (US)
- ORCID
- Berk, Bradford C.
- Venue
- Arteriosclerosis, Thrombosis, and Vascular Biology
- Published
- 2008-04
- Volume
- 28
- Issue
- 4
- Pages
- 711-717
- ISSN
- 1079-5642 (ISSN-L)
- 1524-4636
- OpenAlex
- W2080180491
- Cited by
- 120
- References
- 30
- Citations by year
- 2026: 4 · 2025: 7 · 2024: 7 · 2023: 10 · 2022: 5 · 2021: 8 · 2020: 9 · 2019: 3 · 2018: 4 · 2017: 10 · 2016: 6 · 2015: 6 · 2014: 4 · 2013: 13 · 2012: 7
- FWCI
- 3.84
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Arteriosclerosis Thrombosis and Vascular Biology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Health Sciences › Medicine › Oncology › PARP inhibition in cancer therapy
- Keywords
- PARP1 inhibition, oxidative stress, nitrosative stress, endothelial cell death, VEGF receptor 2, Akt signaling, Bad phosphorylation, NAD+ depletion, ATP depletion, hydrogen peroxide, peroxynitrite, PJ34, endothelial cell survival, apoptosis, human umbilical vein endothelial cells
- MeSH terms
- Poly(ADP-ribose) Polymerase Inhibitors, Poly (ADP-Ribose) Polymerase-1, Adenosine Triphosphate, Cells, Cultured, Cinnamates, Enzyme Inhibitors, Humans, NAD, Oxidation-Reduction, Phenanthrenes, Poly(ADP-ribose) Polymerases, Transcriptional Activation, Nitrosation, Cell Death, Apoptosis, Oxidative Stress, Reactive Nitrogen Species, RNA, Small Interfering, Vascular Endothelial Growth Factor Receptor-2, Endothelial Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review